Dose-independent pharmacokinetics of a new reversible proton pump inhibitor, KR-60436, after intravenous and oral administration to rats: gastrointestinal first-pass effect.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples